Smith & Nephew : Improvement in the margin only on higher growth and fixing orthopaedics
>Improvement in underlying growth is positive, but trading margin still weak - Over recent quarters, Smith & Nephew has shown an improvement in top line momentum, which resulted in strong underlying growth of 7.2% in comparison to only a low single-digit level on average in previous years. This has come in particular on a better performance at Orthopaedics. However, the stronger growth does not convert into a higher profitability. FY 2024 trading margin of 17.5% compa...Smith & Nephew is a global medical devices business operating in the markets for advanced surgical devices comprising orthopaedic reconstruction and trauma, sports medicine and advanced wound management. Co.'s advanced medical products and services include: Orthopaedic Reconstruction and Trauma (joint replacement systems for knees and hips and products to help repair broken bones); Advanced Wound Management (treatment and prevention products for hard-to-heal wounds); and Sports Medicine (implants and enabling technologies for minimally invasive repair of the joint).
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.